Accelerate Diagnostics Inc (NASDAQ:AXDX) Investor NOTICE: Investigation over Possible Violations of Securities Laws
An investigation for investors in Accelerate Diagnostics Inc (NASDAQ:AXDX) shares over potential securities laws violations by Accelerate Diagnostics was announced and NASDAQ:AXDX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWire) -- 03/16/2015 --An investigation on behalf of investors of Accelerate Diagnostics Inc (NASDAQ:AXDX) shares over potential securities laws violations by Accelerate Diagnostics and certain of its directors and officers in connection certain financial statements was announced.
Investors who purchased shares of Accelerate Diagnostics Inc (NASDAQ:AXDX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Accelerate Diagnostics Inc (NASDAQ:AXDX) concerning whether Accelerate Diagnostics may have issued materially misleading business information to the investing public.
Accelerate Diagnostics Inc reported that its Net Loss increased from $15.28 million in 2013 to $30.93 million in 2014. Shares of Accelerate Diagnostics Inc (NASDAQ:AXDX) grew from under $1 per share in April 2012 to as high as $30.08 per share in June 2014, respectively $28.78 per share in October 2014.
On February 18, 2015, an article was published that asserted that Accelerate Diagnostics Inc falsely claimed that it had developed a technique for diagnosing pathogens in a blood sample without a need for using a blood culture, while in reality, the test required a blood culture, a fact that significantly reduced the value of the technology. Shares of Accelerate Diagnostics Inc (NASDAQ:AXDX0 declined to as low as $17.29 per share on February 23, 2015.
On March 12, 2015, NASDAQ:AXDX shares closed at $19.72.
Those who purchased shares of Accelerate Diagnostics Inc (NASDAQ:AXDX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Media Relations Contact
Michael Daniels
General Manager
Shareholders Foundation
858-779-1554
http://www.ShareholdersFoundation.com
View this press release online at: http://rwire.com/586169